title: Managing antiplatelet and anticoagulant drugs in patients undergoing elective ophthalmic surgery. Authors' response.
authors.affiliation: Oxford Eye Hospital, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK.
authors.forename: Rajarshi
authors.initials: R
authors.lastname: Mukherjee
authors.affiliation: Oxford Eye Hospital, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK.
authors.forename: Christine A
authors.initials: CA
authors.lastname: Kiire
authors.affiliation: Department of Cardiology, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK.
authors.forename: Neil
authors.initials: N
authors.lastname: Ruparelia
authors.affiliation: Department of Haematology, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK.
authors.forename: David
authors.initials: D
authors.lastname: Keeling
authors.affiliation: Department of Cardiology, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK.
authors.forename: Bernard
authors.initials: B
authors.lastname: Prendergast
authors.affiliation: Oxford Eye Hospital, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK.
authors.forename: Jonathan H
authors.initials: JH
authors.lastname: Norris
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D002387:Cataract Extraction / Q000009:adverse effects*; D002832:Choroid Hemorrhage / Q000517:prevention & control*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors
keywords: Drugs